Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

RISE – Chemical and Pharmaceutical Safety

Reference number
Coordinator RISE Research Institutes of Sweden AB - Ytor, Process och Formulering, Stockholm
Funding from Vinnova SEK 10 000 000
Project duration January 2019 - December 2022
Status Ongoing

Purpose and goal

The long-term aim is to build up the activities of the new section, RISE - Chemical and pharmaceutical Safety, to meet the needs of society, industry and academia for toxicological safety assessments and hence secure a national infrastructure within the whole drug development chain. The section will also complement and collaborate with the Life Science ecosystems nationally and internationally. The goal is that the section RISE-Chemical and Pharmaceutical Safety will be self-supporting after 4 years of start-up funding.

Expected results and effects

The great expertise and experience that has been built up in the infrastructure of Swetox / Gärtuna will be secured through the transition to RISE. Thus, current and future needs for safety assessments of new materials and pharmaceuticals will be available to society, academia and industry, both nationally and internationally.

Planned approach and implementation

The following activities will be performed in the project: 1)Start-up / conversion: Introduction to RISE systems and collaboration within RISE etc. Infrastructure: Purchase of mobiles, access to databases, licenses and IT infrastructure 2)Business development: Presentation and development of the offer incl. taking new contacts, travel, and method development etc. 3)Research: Supervision of PhD students, post docs and diploma workers, participation at conferences and method development etc.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 27 March 2019

Reference number 2019-00077

Page statistics